775
Views
3
CrossRef citations to date
0
Altmetric
Reviews

Aerobic capacity in persons with Parkinson’s disease: a systematic review

ORCID Icon, ORCID Icon, , ORCID Icon, & ORCID Icon
Pages 2409-2421 | Received 26 Oct 2021, Accepted 19 Jun 2022, Published online: 10 Jul 2022

References

  • Tysnes OB, Storstein A. Epidemiology of Parkinson's disease. J Neural Transm. 2017;124(8):901–905.
  • Understanding-Parkinsons; 2022. Available from: https://www.parkinson.org/Understanding-Parkinsons/Statistics
  • GBD 2015 Neurological Disorders Collaborator Group. Global, regional, and national burden of neurological disorders during 1990–2015: a systematic analysis for the global burden of disease study 2015. Lancet Neurol. 2017;16(11):877–897.
  • Armstrong MJ, Okun MS. Diagnosis and treatment of Parkinson disease: a review. JAMA. 2020;323(6):548–560.
  • Alberts JL, Rosenfeldt AB. The universal prescription for Parkinson’s disease: exercise. J Parkinsons Dis. 2020;10(Suppl. 1):S21–S27.
  • Cavanaugh JT, Ellis TD, Earhart GM, et al. Toward understanding ambulatory activity decline in Parkinson disease. Phys Ther. 2015;95(8):1142–1150.
  • Lord S, Godfrey A, Galna B, et al. Ambulatory activity in incident Parkinson's: more than meets the eye? J Neurol. 2013;260(12):2964–2972.
  • van Nimwegen M, Speelman AD, Hofman-van Rossum EJ, et al. Physical inactivity in Parkinson's disease. J Neurol. 2011;258(12):2214–2221.
  • Canning CG, Alison JA, Allen NE, et al. Parkinson's disease: an investigation of exercise capacity, respiratory function, and gait. Arch Phys Med Rehabil. 1997;78(2):199–207.
  • Warburton DE, Nicol CW, Bredin SS. Health benefits of physical activity: the evidence. CMAJ. 2006;174(6):801–809.
  • Bassett DR Jr., Howley ET. Limiting factors for maximum oxygen uptake and determinants of endurance performance. Med Sci Sports Exerc. 2000;32(1):70–84.
  • Carnethon MR, Gulati M, Greenland P. Prevalence and cardiovascular disease correlates of low cardiorespiratory fitness in adolescents and adults. JAMA. 2005;294(23):2981–2988.
  • Eriksen L, Curtis T, Grønbaek M, et al. The association between physical activity, cardiorespiratory fitness and self-rated health. Prev Med. 2013;57(6):900–902.
  • Kodama S, Saito K, Tanaka S, et al. Cardiorespiratory fitness as a quantitative predictor of all-cause mortality and cardiovascular events in healthy men and women: a meta-analysis. JAMA. 2009;301(19):2024–2035.
  • Langeskov-Christensen M, Heine M, Kwakkel G, et al. Aerobic capacity in persons with multiple sclerosis: a systematic review and meta-analysis. Sports Med. 2015;45(6):905–923.
  • Mak MKY, Wong-Yu ISK. Exercise for Parkinson's disease. Int Rev Neurobiol. 2019;147:1–44.
  • Schootemeijer S, van der Kolk NM, Bloem BR, et al. Current perspectives on aerobic exercise in people with Parkinson’s disease. Neurotherapeutics. 2020;17(4):1418–1433.
  • Stickland MK, Butcher SJ, Marciniuk DD, et al. Assessing exercise limitation using cardiopulmonary exercise testing. Pulm Med. 2012;2012:824091.
  • Prisma-statement; 2022. Available from: http://prisma-statement.org/Default.aspx
  • Covidence; 2022. Available from: https://www.covidence.org
  • Brian J, Whipp PD. The peak versus maximum oxygen uptake issue. Leeds (UK): Institute of Membrane and Systems Biology University of Leeds; 2015.
  • Edvardsen E, Hem E, Anderssen SA. End criteria for reaching maximal oxygen uptake must be strict and adjusted to sex and age: a cross-sectional study. PLOS One. 2014;9(1):e85276.
  • Howley ET, Bassett DR Jr., Welch HG. Criteria for maximal oxygen uptake: review and commentary. Med Sci Sports Exerc. 1995;27(9):1292–1301.
  • Midgley AW, McNaughton LR, Polman R, et al. Criteria for determination of maximal oxygen uptake: a brief critique and recommendations for future research. Sports Med. 2007;37(12):1019–1028.
  • Mokkink LB, Terwee CB, Patrick DL, et al. The COSMIN study reached international consensus on taxonomy, terminology, and definitions of measurement properties for health-related patient-reported outcomes. J Clin Epidemiol. 2010;63(7):737–745.
  • Roach KE. Measurement of health outcomes: reliability, validity and responsiveness. J Prosthet Orthot. 2006;18(6):P8–P12.
  • Hopkins WG. Measures of reliability in sports medicine and science. Sports Med. 2000;30(1):1–15.
  • Vaz S, Falkmer T, Passmore AE, et al. The case for using the repeatability coefficient when calculating test–retest reliability. PLOS One. 2013;8(9):e73990.
  • Husted JA, Cook RJ, Farewell VT, et al. Methods for assessing responsiveness: a critical review and recommendations. J Clin Epidemiol. 2000;53(5):459–468.
  • van der Kolk NM, de Vries NM, Penko AL, et al. A remotely supervised home-based aerobic exercise programme is feasible for patients with Parkinson's disease: results of a small randomised feasibility trial. J Neurol Neurosurg Psychiatry. 2018;89(9):1003–1005.
  • Sacheli MA, Neva JL, Lakhani B, et al. Exercise increases caudate dopamine release and ventral striatal activation in Parkinson's disease. Mov Disord. 2019;34(12):1891–1900.
  • van der Kolk NM, de Vries NM, Kessels RPC, et al. Effectiveness of home-based and remotely supervised aerobic exercise in Parkinson's disease: a double-blind, randomised controlled trial. Lancet Neurol. 2019;18(11):998–1008.
  • Strano S, Fanciulli A, Rizzo M, et al. Cardiovascular dysfunction in untreated Parkinson's disease: a multi-modality assessment. J Neurol Sci. 2016;370:251–255.
  • Johansson ME, Cameron IGM, Van der Kolk NM, et al. Aerobic exercise alters brain function and structure in Parkinson's disease: a randomized controlled trial. Ann Neurol. 2022;91(2):203–216.
  • Ivey FM, Katzel LI, Sorkin JD, et al. The Unified Parkinson's Disease Rating Scale as a predictor of peak aerobic capacity and ambulatory function. J Rehabil Res Dev. 2012;49(8):1269–1276.
  • Katzel LI, Ivey FM, Sorkin JD, et al. Impaired economy of gait and decreased six-minute walk distance in Parkinson's disease. Parkinson's Dis. 2012;2012:1–6.
  • Katzel LI, Sorkin JD, Macko RF, et al. Repeatability of aerobic capacity measurements in Parkinson disease. Med Sci Sports Exerc. 2011;43(12):2381–2387.
  • Shulman LM, Katzel LI, Ivey FM, et al. Randomized clinical trial of 3 types of physical exercise for patients with Parkinson disease. JAMA Neurol. 2013;70(2):183–190.
  • DiFrancisco-Donoghue J, Elokda A, Lamberg EM, et al. Norepinephrine and cardiovascular responses to maximal exercise in Parkinson's disease on and off medication. Mov Disord. 2009;24(12):1773–1778.
  • Elokda A, DiFrancisco-Donoghue J, Lamberg EM, et al. Effects of exercise induced oxidative stress on glutathione levels in Parkinson's disease on and off medication. J Neurol. 2010;257(10):1648–1653.
  • Lyytinen J, Kaakkola S, Gordin A, et al. The effect of COMT inhibition with entacapone on cardiorespiratory responses to exercise in patients with Parkinson's disease. Parkinsonism Relat Disord. 2002;8(5):349–355.
  • Schenkman M, Moore CG, Kohrt WM, et al. Effect of high-intensity treadmill exercise on motor symptoms in patients with de novo Parkinson disease: a phase 2 randomized clinical trial. JAMA Neurol. 2018;75(2):219–226.
  • Haas B, Cinnamond S, Hunter H, et al. Factors associated with limited exercise capacity and feasibility of high intensity interval training in people with mild to moderate Parkinson's disease. Int J Ther Rehabil. 2016;23(9):414–422.
  • Mavrommati F, Collett J, Franssen M, et al. Exercise response in Parkinson's disease: insights from a cross-sectional comparison with sedentary controls and a per-protocol analysis of a randomised controlled trial. BMJ Open. 2017;7(12):e017194.
  • Burini D, Farabollini B, Iacucci S, et al. A randomised controlled cross-over trial of aerobic training versus Qigong in advanced Parkinson's disease. Eura Medicophys. 2006;42(3):231–238.
  • Demonceau M, Maquet D, Jidovtseff B, et al. Effects of twelve weeks of aerobic or strength training in addition to standard care in Parkinson's disease: a controlled study. Eur J Phys Rehabil Med. 2017;53(2):184–200.
  • Garber CE, Friedman JH. Effects of fatigue on physical activity and function in patients with Parkinson's disease. Neurology. 2003;60(7):1119–1124.
  • Kanegusuku H, Silva-Batista C, Peçanha T, et al. Blunted maximal and submaximal responses to cardiopulmonary exercise tests in patients with Parkinson disease. Arch Phys Med Rehabil. 2016;97(5):720–725.
  • Kurtais Y, Kutlay S, Tur BS, et al. Does treadmill training improve lower-extremity tasks in Parkinson disease? A randomized controlled trial. Clin J Sport Med. 2008;18(3):289–291.
  • Penko AL, Zimmerman NM, Crawford M, et al. Effect of aerobic exercise on cardiopulmonary responses and predictors of change in individuals with Parkinson's disease. Arch Phys Med Rehabil. 2021;102(5):925–931.
  • Protas EJ, Stanley RK, Jankovic J, et al. Cardiovascular and metabolic responses to upper- and lower-extremity exercise in men with idiopathic Parkinson's disease. Phys Ther. 1996;76(1):34–40.
  • Stanley RK, Protas EJ, Jankovic J. Exercise performance in those having Parkinson's disease and healthy normals. Med Sci Sports Exerc. 1999;31(6):761–766.
  • Steib S, Wanner P, Adler W, et al. A single bout of aerobic exercise improves motor skill consolidation in Parkinson's disease. Front Aging Neurosci. 2018;10(328):328.
  • Uc EY, Doerschug KC, Magnotta V, et al. Phase I/II randomized trial of aerobic exercise in Parkinson disease in a community setting. Neurology. 2014;83(5):413–425.
  • Bergen JL, Toole T, Elliott RG 3rd, et al. Aerobic exercise intervention improves aerobic capacity and movement initiation in Parkinson's disease patients. NeuroRehabilitation. 2002;17(2):161–168.
  • Harvey M, Weston KL, Gray WK, et al. High-intensity interval training in people with Parkinson's disease: a randomized, controlled feasibility trial. Clin Rehabil. 2019;33(3):428–438.
  • Penko AL, Barkley JE, Koop MM, et al. Borg scale is valid for ratings of perceived exertion for individuals with Parkinson's disease. Int J Exerc Sci. 2017;10(1):76–86.
  • Kanegusuku H, Peçanha T, Silva-Batista C Jr., et al. Effects of resistance training on metabolic and cardiovascular responses to a maximal cardiopulmonary exercise test in Parkinson’s disease. Einstein. 2021;19:eAO5940.
  • Langeskov-Christensen M, Langeskov-Christensen D, Overgaard K, et al. Validity and reliability of VO(2)-max measurements in persons with multiple sclerosis. J Neurol Sci. 2014;342(1–2):79–87.
  • Heine M, van den Akker LE, Verschuren O, et al. Reliability and responsiveness of cardiopulmonary exercise testing in fatigued persons with multiple sclerosis and low to mild disability. PLOS One. 2015;10(3):e0122260.
  • Norwitz NG, Dearlove DJ, Lu M, et al. A ketone ester drink enhances endurance exercise performance in Parkinson's disease. Front Neurosci. 2020;14:584130.
  • Magnan RE, Kwan BM, Ciccolo JT, et al. Aerobic capacity testing with inactive individuals: the role of subjective experience. J Phys Act Health. 2013;10(2):271–279.
  • Swank C, Shearin S, Cleveland S, et al. Auditing the physical activity and Parkinson disease literature using the behavioral epidemiologic framework. PM R. 2017;9(6):612–621.
  • Canning CG, Ada L, Johnson JJ, et al. Walking capacity in mild to moderate Parkinson's disease. Arch Phys Med Rehabil. 2006;87(3):371–375.
  • Dunnewold RJ, Hoff JI, van Pelt HC, et al. Ambulatory quantitative assessment of body position, bradykinesia, and hypokinesia in Parkinson's disease. J Clin Neurophysiol. 1998;15(3):235–242.
  • Bjørke ACH, Raastad T, Berntsen S. Criteria for the determination of maximal oxygen uptake in patients newly diagnosed with cancer: baseline data from the randomized controlled trial of physical training and cancer (Phys-Can). PLOS One. 2020;15(6):e0234507.
  • Martínez-Martín P, Rodríguez-Blázquez C, Mario A, et al. Parkinson's disease severity levels and MDS-Unified Parkinson's Disease Rating Scale. Parkinsonism Relat Disord. 2015;21(1):50–54.
  • Ebersbach G, Baas H, Csoti I, et al. Scales in Parkinson's disease. J Neurol. 2006;253(Suppl. 4):IV32–IV35.
  • Tanji H, Gruber-Baldini AL, Anderson KE, et al. A comparative study of physical performance measures in Parkinson's disease. Mov Disord. 2008;23(13):1897–1905.
  • Brusse KJ, Zimdars S, Zalewski KR, et al. Testing functional performance in people with Parkinson disease. Phys Ther. 2005;85(2):134–141.
  • Christiansen CL, Schenkman ML, McFann K, et al. Walking economy in people with Parkinson's disease. Mov Disord. 2009;24(10):1481–1487.
  • Ahlskog JE. Does vigorous exercise have a neuroprotective effect in Parkinson disease? Neurology. 2011;77(3):288–294.
  • Ahlskog JE. Aerobic exercise: evidence for a direct brain effect to slow Parkinson disease progression. Mayo Clin Proc. 2018;93(3):360–372.
  • Heine M, van de Port I, Rietberg MB, et al. Exercise therapy for fatigue in multiple sclerosis. Cochrane Database Syst Rev. 2015;(9):CD009956.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.